Logo image of CYRN

CYREN LTD (CYRN) Stock Fundamental Analysis

NASDAQ:CYRN - Nasdaq - IL0010832371 - Common Stock - Currency: USD

0.2182  -0.06 (-20.65%)

After market: 0.204 -0.01 (-6.51%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CYRN. CYRN was compared to 283 industry peers in the Software industry. Both the profitability and financial health of CYRN have multiple concerns. CYRN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year CYRN has reported negative net income.
CYRN had a negative operating cash flow in the past year.
CYRN Yearly Net Income VS EBIT VS OCF VS FCFCYRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 -5M -10M -15M -20M

1.2 Ratios

CYRN has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CYRN Yearly ROA, ROE, ROICCYRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 -50 -100 -150

1.3 Margins

The Gross Margin of CYRN (44.77%) is worse than 70.90% of its industry peers.
CYRN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CYRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5%
GM growth 5Y-5.47%
CYRN Yearly Profit, Operating, Gross MarginsCYRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 50 -50

2

2. Health

2.1 Basic Checks

CYRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
CYRN has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, CYRN has an improved debt to assets ratio.
CYRN Yearly Shares OutstandingCYRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M
CYRN Yearly Total Debt VS Total AssetsCYRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -13.46, we must say that CYRN is in the distress zone and has some risk of bankruptcy.
CYRN's Altman-Z score of -13.46 is on the low side compared to the rest of the industry. CYRN is outperformed by 90.64% of its industry peers.
A Debt/Equity ratio of 2.30 is on the high side and indicates that CYRN has dependencies on debt financing.
CYRN has a worse Debt to Equity ratio (2.30) than 81.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.3
Debt/FCF N/A
Altman-Z -13.46
ROIC/WACCN/A
WACC3.12%
CYRN Yearly LT Debt VS Equity VS FCFCYRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M 40M

2.3 Liquidity

A Current Ratio of 1.29 indicates that CYRN should not have too much problems paying its short term obligations.
CYRN has a worse Current ratio (1.29) than 65.22% of its industry peers.
CYRN has a Quick Ratio of 1.29. This is a normal value and indicates that CYRN is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.29, CYRN is not doing good in the industry: 64.21% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.29
CYRN Yearly Current Assets VS Current LiabilitesCYRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M

1

3. Growth

3.1 Past

CYRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.04%, which is quite impressive.
Looking at the last year, CYRN shows a very negative growth in Revenue. The Revenue has decreased by -13.53% in the last year.
Measured over the past years, CYRN shows a small growth in Revenue. The Revenue has been growing by 0.13% on average per year.
EPS 1Y (TTM)23.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
Revenue 1Y (TTM)-13.53%
Revenue growth 3Y-4.58%
Revenue growth 5Y0.13%
Sales Q2Q%3.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CYRN Yearly Revenue VS EstimatesCYRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M
CYRN Yearly EPS VS EstimatesCYRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 -2 -4 -6

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CYRN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CYRN Price Earnings VS Forward Price EarningsCYRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CYRN Per share dataCYRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CYRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CYREN LTD

NASDAQ:CYRN (3/2/2023, 8:00:01 PM)

After market: 0.204 -0.01 (-6.51%)

0.2182

-0.06 (-20.65%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-21 2023-02-21
Earnings (Next)05-15 2023-05-15
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners46.3%
Ins Owner Change0%
Market Cap1.75M
Analysts82.86
Price Target1.53 (601.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B 0.46
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.54
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)-1.57
OCFYN/A
SpS3.08
BVpS0.47
TBVpS-0.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.77%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5%
GM growth 5Y-5.47%
F-Score3
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 2.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.66%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.29
Altman-Z -13.46
F-Score3
WACC3.12%
ROIC/WACCN/A
Cap/Depr(3y)23.38%
Cap/Depr(5y)32.05%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.53%
Revenue growth 3Y-4.58%
Revenue growth 5Y0.13%
Sales Q2Q%3.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.44%
OCF growth 3YN/A
OCF growth 5YN/A